An investigation of Temperament and Character Inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder

被引:7
|
作者
Tomita, Tetsu [1 ]
Ishioka, Masamichi [1 ]
Kaneda, Ayako [1 ]
Sugawara, Norio [1 ]
Nakagami, Taku [1 ]
Nakamura, Kazuhiko [1 ]
Yasui-Furukori, Norio [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan
关键词
Temperament and Character Inventory; Prediction; Paroxetine treatment; Major depressive disorder; PERSONALITY-DISORDER; MOOD DISORDERS; POLYMORPHISMS; OUTPATIENTS; SEROTONIN; PROFILES; TRAITS; STATES; MODEL; TCI;
D O I
10.1016/j.jad.2014.04.076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Previous studies have reported associations between Temperament and Character Inventory (TCI) dimension scores and the response to treatment in patients with major depressive disorder (MDD). We aimed to determine which TCI items could predict the response to treatment with paroxetine in patients with MDD. Methods: Seventy-three patients were enrolled in this study. The participants were treated with 10-40 mg/day of paroxetine for six weeks; they then completed the TCI. The Montgomery-Asberg Depression Rating Scale (MADRS) was used to evaluate the patients. The participants were divided into two groups (responders and non-responders). We used a chi-squared test to identify the 10 items with the strongest association with treatment response from among all 240 items on the TCI, and we used a multiple logistic regression analysis to confirm the validity of these 10 items. Results: Among the TCI dimension scores, only the C score differed significantly between the two groups. We analyzed 10 models using each of the 10 best items. All the models significantly predicted treatment response. The TCI dimensions model also significantly predicted treatment response, but its predictive value was lower than those of the other 10 models. Limitations: The responders included the early responders. The results lacked information about responders whose responses were not predicted by the logistic regression models and TCI items. Conclusions: Some TCI items showed significant associations with the response to paroxetine treatment in the patients with MDD. Treatment response in patients with MDD may be predicted using only 10 items from the TCI. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 50 条
  • [41] Monitoring the Response of Treatment in Major Depressive Disorder with EEG: Could it be an Indicator of Returning to Health in Responders
    Arikan, Mehmet Kemal
    Gica, Sakir
    Ilhan, Reyhan
    Orhan, Ozden
    Kalaba, Oznur
    Gunver, Mehmet Guven
    CLINICAL EEG AND NEUROSCIENCE, 2025,
  • [42] Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
    Kern, David M. M.
    Canuso, Carla M. M.
    Daly, Ella
    Johnson, Jonathan C. C.
    Fu, Dong Jing
    Doherty, Teodora
    Blauer-Peterson, Cori
    Cepeda, M. Soledad
    BRAIN AND BEHAVIOR, 2023,
  • [43] Predicting tDCS treatment outcomes of patients with major depressive disorder using automated EEG classification
    Al-Kaysi, Alaa M.
    Al-Ani, Ahmed
    Loo, Colleen K.
    Powell, Tamara Y.
    Martin, Donel M.
    Breakspear, Michael
    Boonstra, Tjeerd W.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 208 : 597 - 603
  • [44] 6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorder
    Freitas, Juliana Jury
    Xavier, Nicoli Bertuol
    Tonon, Andre Comiran
    Carissimi, Alicia
    Pizutti, Leandro Timm
    Vieira Ilgenfritz, Carlos Augusto
    Markus, Regina Pekelmann
    Hidalgo, Maria Paz
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
  • [45] Atypical depressive symptoms as a predictor of treatment response to exercise in Major Depressive Disorder
    Rethorst, Chad D.
    Tu, Jian
    Carmody, Thomas J.
    Greer, Tracy L.
    Trivedi, Madhukar H.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 200 : 156 - 158
  • [46] Th2 cytokine response in Major Depressive Disorder patients before treatment
    Pavón, L
    Sandoval-López, G
    Hernández, ME
    Loría, F
    Estrada, I
    Pérez, M
    Moreno, J
    Avila, U
    Leff, P
    Antón, B
    Heinze, G
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 172 (1-2) : 156 - 165
  • [47] CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients
    Taro Kishi
    Tsuyoshi Kitajima
    Masashi Ikeda
    Yoshio Yamanouchi
    Yoko Kinoshita
    Kunihiro Kawashima
    Tomo Okochi
    Takenori Okumura
    Tomoko Tsunoka
    Norio Ozaki
    Nakao Iwata
    NeuroMolecular Medicine, 2009, 11 : 53 - 57
  • [48] Importance of achieving rapid treatment response in major depressive disorder
    Alva, Gustavo
    CNS SPECTRUMS, 2023, 28 (05) : 521 - 525
  • [49] A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder
    Khodayari-Rostamabad, Ahmad
    Reilly, James P.
    Hasey, Gary M.
    de Bruin, Hubert
    MacCrimmon, Duncan J.
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (10) : 1975 - 1985
  • [50] A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder
    Kasper, S
    Olivieri, L
    Di Loreto, G
    Dionisio, P
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1139 - 1146